CDK6 and medulloblastoma: The re-expression of miR-124 in medulloblastoma cells decreased expression of CDK6 protein, which is known to be an important regulator of cell cycle progression.[8] It is important to note that overexpression of CDK6 has been shown to correlate significantly with poor prognosis in medulloblastoma.